Anazarka Tarzı Ödem ile Başvuran İki̇ Sütçocuğu: Protei̇n Kaybetti̇ren Enteropati̇ti̇
Protein kaybettiren enteropati (PKE) serum proteinlerinin gastrointestinal sistemden kaybı ve hipoproteinemi gelişimiile karakterize bir tablodur. Ödem, asit, malnütrisyon plevral veperikardiyal efüzyon ile komplike hale gelebilir. Nadirgörülmekle birlikte bir çok durum PKEye neden olabilir. PKE nedenleri eroziv- noneroziv gastrointestinal hastalıklar,santral venöz basınç artışı ile karakterize hastalıklar ve mezenterik lenfatik obstrüksiyon gelişimi ile karakterize olanlarolarak gruplanabilir. PKE tanısı, hipoproteinemi ile başvuran bir hastada malnütrisyon, proteinüri ve bozulmuş proteinsentezi ile giden hastalıklar dışlandıktan sonra konulmalıdır. Tedavi, diyet modifi kasyonunu da içeren destek tedavidenoluşur. Bu yazıda, farklı nedenlerle anazarka tarzı ödem ile başvuran ve farklı etiyolojilerle protein kaybettiren enteropatitanısı alan iki sütçocuğu sunulmuştur.
Two Infants Applying with Anasarca-Type Edema: Protein-Losing Enteropathy
rotein-losing enteropathy (PLE) is characterized by the development of hypoproteinemia and the loss of serum proteinsfrom the gastrointestinal system. It can be complicated with edema, acid, malnutrition, and pleural and pericardialeffusion. PLE is rare but has many causes. The reasons can be grouped as erosive and non-erosive gastrointestinaldiseases, diseases characterized by central venous pressure increase, and diseases characterized by the developmentof mesenteric lymphatic obstruction. A PLE diagnosis should be made for the patient who presents with hypoproteinemiaafter excluding other disorders causing malnutrition, proteinuria and impaired protein synthesis. Treatment consists of asupportive treatment that includes dietary modifi cation. This paper presents two infants who developed anasarca-typeedema following different causes and were diagnosed with protein-losing enteropathy due to different etiologies.
___
- 1. Uzuner O, Ziessman HA. Protein-losing enteropathy detected by Tc-99m-MDP abdominal scintigraphy. Pediatr Radiol 2008;38: 1122-4.
- 2. Umar SB. DiBaise JK. Protein-losing Enteropathy: Case IIlustrati- ons and Clinical Review. Am J Gastroenterol 2010;105:43-9.
- 3. Takeda H, Ishihama K, Fukui T, Fujishima S, Orii T, Nakazawa Y, et al. Signifi cance of rapid turnover proteins in protein-losing gastroenteropathy. Hepatogastroenterol 2003;50:1963-5.
- 4. Waldmann TA, Steinfeld JL, Dutcher TF, Davidson JD, Gordon RS Jr. The role of the gastrointestinal system in idiopathic hypoproteinemia. Gastroenterology 1961;41:197-207.
- 5. Braamskamp MJ, Dolman KM, Tabbers MM. Clinical practice. Protein-losing enteropathy in children. Eur J Pediatr 2010;169: 1179-85.
- 6. Proujansky R. Protein-losing enteropathy. In: Walker J (ed). Pediatric Gastrointestinal Disease. 3rd edn. BC Becker, Hamilton, 2000:89-95.
- 7. Feldt RH, Driscoll DJ, Offord KP, Cha RH, Perrault J, Schaff HV, et al. Proteinlosing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 1996;112:672-80.
- 8. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein- losing enteropathy after the Fontan operation: An international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998;115:1063-73.
- 9. Stiehm ER. Human intravenous immunoglobulin in primary and secondary antibody defi ciencies. Pediatr Infect Dis J 1997;16: 696-707.
- 10. Takeda H, Nishise S, Furukawa M, Nagashima R, Shinzawa H, Takahashi T. Fecal clearance of ά1-antitrypsin with lansoprazole can detect protein-losing gastropathy. Dig Dis Sci 1996;44: 2313-8.
- 11. Lee KH, Chung JK, Lee DS, Lee MC, Song IS, Koh CS. Intestinal leakage of technetium-99m-MDP in primary intestinal lymphangiectasia. J Nucl Med 1996;37:639-41.
- 12. Puri AS, Aggarwal R Gupta RK, Sewatkar AB, Gambhir S, Tandon P, et al. Intestinal lymphangiectasia: evaluation by CT and scintigraphy. Gastrointest Radiol 1992;17:119-21.
- 13. Liu NF, Lu Q, Wang CG, Zhou JG. Magnetic resonance imaging as a new method to diagnose protein losing enteropathy. Lymphology 2008;41:111-5.
- 14. Desai A, Guvenc B, Carachi R. Evidence for medium chain triglycerides in the treatment of primary intestinal lymphangiectasia. Eur J Ped Surg 2009; 19:241-5.
- 15. Bendayán I, Casaldaliga J, Castelló F, Miró L. Heparin therapy and reversal of protein-losing enteropathy in a case with congenital heart disease. Pediatr Cardiol 2000; 21:267-8.
- 16. Fushimi T, Takahashi Y, Kashima Y, Fukushima K, Ishii W, Kaneko K, et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid 2005;12:48-53.
- 17. Ringel RE, Peddy SB. Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease. Am J Cardiol 2003;91:1031-2.